dc.contributor.author | Lisby, Michael | |
dc.contributor.author | Straub, Tobias | |
dc.contributor.author | Olesen, Jens R. | |
dc.contributor.author | Skouboe, Camilla | |
dc.contributor.author | Krogh, Berit O. | |
dc.contributor.author | Boege, Fritz | |
dc.contributor.author | Velmurugan, Soundarapaudian | |
dc.contributor.author | Martensen, Pia M. | |
dc.contributor.author | Andersen, Anni H. | |
dc.contributor.author | Jayaram, Makkuni | |
dc.contributor.author | Westergaard, Ole | |
dc.contributor.author | Knudsen, Birgitta R. | |
dc.date.accessioned | 2025-06-20T09:55:31Z | |
dc.date.available | 2025-06-20T09:55:31Z | |
dc.date.issued | 2001-01-01 | |
dc.description.abstract | All eukaryotic forms of DNA topoisomerase I contain an extensive and highly charged N-terminal domain. This domain contains several nuclear localization sequences and is essential for in vivo function of the enzyme. However, so far no direct function of the N-terminal domain in the in vitro topoisomerase I reaction has been reported. In this study we have compared the in vitro activities of a truncated form of human topoisomerase I lacking amino acids 1-206 (p67) with the full-length enzyme (p91). Using these enzyme forms, we have identified for the first time a direct role of residues within the N-terminal domain in modulating topoisomerase I catalysis, as revealed by significant differences between p67 and p91 in DNA binding, cleavage, strand rotation, and ligation. A comparison with previously published studies showing no effect of deleting the first 174 or 190 amino acids of topoisomerase I (Stewart, L., Ireton, G. C., and Champoux, J. J. (1999) J. Biol. Chem. 274, 32950-32960; Bronstein, I. B., Wynne-Jones, A., Sukhanova, A., Fleury, F., Ianoul, A., Holden, J. A., Alix, A. J., Dodson, G. G., Jardillier, J. C., Nabiev, I., and Wilkinson, A. J. (1999) Anticancer Res. 19, 317-327) suggests a pivotal role of amino acids 191-206 in catalysis. Taken together the presented data indicate that at least part(s) of the N-terminal domain regulate(s) enzyme/DNA dynamics during relaxation most probably by controlling non-covalent DNA binding downstream of the cleavage site either directly or by coordinating DNA contacts by other parts of the enzyme. | |
dc.description.epage | 20227 | |
dc.description.spage | 20220 | |
dc.description.volume | 276 | |
dc.identifier.doi | 10.1074/jbc.m010991200 | |
dc.identifier.issn | 0021-9258 | |
dc.identifier.openaire | doi_dedup___:fe33b419f2d90e961fbde7667386b991 | |
dc.identifier.pmid | 11283003 | |
dc.identifier.uri | https://trapdev.rcub.bg.ac.rs/handle/123456789/1354233 | |
dc.openaire.affiliation | Aarhus University | |
dc.openaire.collaboration | 1 | |
dc.publisher | Elsevier BV | |
dc.rights | OPEN | |
dc.rights.license | CC BY | |
dc.source | Journal of Biological Chemistry | |
dc.subject | DNA Topoisomerases, Type I | |
dc.subject | Protein Conformation | |
dc.subject | Humans | |
dc.subject | Electrophoresis, Polyacrylamide Gel | |
dc.subject | Catalysis | |
dc.subject.fos | 0303 health sciences | |
dc.subject.fos | 03 medical and health sciences | |
dc.title | Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation* | |
dc.type | publication |
Collections
Loading...